4/19
03:09 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
4/19
02:40 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/19
02:40 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/12
10:07 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/12
10:07 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/11
08:06 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
High
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
4/11
06:26 am
phat
Rating for PHAT
High
Report
Rating for PHAT
4/11
06:26 am
phat
Rating for PHAT
High
Report
Rating for PHAT
4/5
09:41 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/5
09:41 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/1
08:08 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
4/1
07:00 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/1
07:00 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/22
02:32 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
3/22
02:12 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/22
02:12 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/18
02:59 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
3/15
10:33 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
3/15
10:33 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
3/8
02:19 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/8
02:19 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/7
12:19 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/7
12:19 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
2/23
10:56 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
2/23
10:40 am
phat
Rating for PHAT
Low
Report
Rating for PHAT